Personalized Cancer Vaccine Keeps Melanoma from Returning

A groundbreaking personalized vaccine combined with an existing drug stopped skin cancer from returning in over 1,000 high-risk patients during a major clinical trial.

The treatment uses the same mRNA technology that powered COVID-19 vaccines to teach each patient's immune system to recognize and destroy their unique cancer cells.